Gem Cis RTin Ca Cervix

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 3

Quimiorradiación concomitante con gemcitabina y cisplatino

en cáncer de cérvix uterino localmente avanzado


Toxicidades
50

45

40

35

30

25
Leve
Severa
20

15

10

Dueñas-González A, Zarba JJ, Alcedo JC, et al. A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin
(Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA
carcinoma of the cervix. J Clin Oncol 27:18s, 2009 (suppl; abstr CRA5507)
Quimiorradiación
concomitante con
gemcitabina y
cisplatino en
cáncer de cérvix
uterino
localmente
avanzado

Dueñas-González A, Zarba JJ,


Alcedo JC, et al. A phase III
study comparing concurrent
gemcitabine (Gem) plus
cisplatin (Cis) and radiation
followed by adjuvant Gem plus
Cis versus concurrent Cis and
radiation in patients with stage
IIB to IVA carcinoma of the
cervix. J Clin Oncol 27:18s,
2009 (suppl; abstr CRA5507)

%
LemaTeachFiles® - 2009
2,8 0,8
Proctitis
Quimiorradiación
concomitante con
Radiodermitis 11 gemcitabina y cisplatino en
cáncer de cérvix uterino
7,7
localmente avanzado
Vómito

Diarra 17

Leve
Severa
Neutropenia febril 1,5 0,8

Trombocitopenia 5,8 0,8

Anemia 7,7 1,5

Neutropenia 45 6

0 10 20 30 40 50 60

Dueñas-González A, Zarba JJ, Alcedo JC, et al. A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin
(Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA
carcinoma of the cervix. J Clin Oncol 27:18s, 2009 (suppl; abstr CRA5507)

You might also like